Federico Gaeta is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions related to tolperisone. With a total of 5 patents to his name, Gaeta's work has the potential to impact therapeutic practices significantly.

Latest Patents

Gaeta's latest patents include innovative methods and compositions involving tolperisone. One of his patents focuses on compositions of tolperisone, which relates to a pharmaceutically acceptable salt or hydrate thereof, with 10 ppm 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) or less. This patent also discusses methods of producing these compositions and treating subjects with tolperisone while limiting their exposure to tolerable levels of 4-MMPPO. Another patent outlines methods of administering tolperisone to subjects in need, emphasizing the importance of limiting exposure to 4-MMPPO during treatment.

Career Highlights

Throughout his career, Federico Gaeta has worked with reputable companies in the pharmaceutical industry, including Sanochemia Pharmazeutika AG and Cytovia, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Gaeta has collaborated with notable professionals in his field, including Stefan Welzig and Jan Rothenburger. These collaborations have likely enriched his work and contributed to the advancements in his patents.

Conclusion

Federico Gaeta's contributions to pharmaceutical innovations, particularly in the area of tolperisone, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to improving therapeutic methods and patient care.

This text is generated by artificial intelligence and may not be accurate.